Physician profile
Robert David Griffith
NPI 1265472195
$1,004.59
in general payments reported to CMS, 2019-2025
12 companies · $60.05 in 2025
The $60.05 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.75 · 2020: $121 · 2021: $252 · 2022: $288 · 2023: $133 · 2024: $72.29 · 2025: $60.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $355.84 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $134.27 | 2020-2023 | Ilumya |
| Galderma Laboratories, L.P. | $104.46 | 2019-2023 | |
| Genzyme Corporation | $91.98 | 2019-2022 | |
| Amgen INC. | $66.77 | 2021-2025 | Otezla |
| Regeneron Healthcare Solutions, INC. | $60.56 | 2020-2023 | Dupixent |
| Leo Pharma INC. | $54.92 | 2020-2023 | Adbry |
| Janssen Biotech, INC. | $45.84 | 2019-2023 | Remicade, Stelara, Simponi Aria |
| Mayne Pharma Commercial LLC | $32.72 | 2020-2022 | |
| Pfizer INC. | $24.68 | 2022 | |
| Almirall LLC | $19.15 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.